Saturday, March 24, 2012

Watson partners with Memorial Sloan-Kettering for some cancer research

Watson partners with Memorial Sloan-Kettering for some cancer research

Supercomputers at the forefront of medical practice. The notion is by no means a stretch of the imagination. Yet, research of this kind mostly goes unnoticed — that is, unless the computational wizardry handholding these advancements belongs to Jeopardy!'s AI king. That's right, Watson, IBM's bold-face named powerhouse of silicon wizardry, will be made available as a development tool for oncologists at Memorial Sloan-Kettering to deliver “individualized cancer diagnostic and treatment recommendations” derived from the center's case note database.

2DayBlog.com, Watson partners with Memorial Sloan-Kettering for some cancer research

No comments:

Post a Comment